Nkarta, Inc. Shareholders' Equity
Nkarta, Inc. (NKTX) had Shareholders' Equity of $247.74 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $247.74M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $285.86M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $312.32M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $337.90M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $247.74M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $285.86M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $312.32M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $337.90M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $357.67M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $378.81M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $407.98M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $430.87M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $453.18M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $473.65M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $273.29M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $296.82M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $317.98M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $346.65M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $372.21M 10-K · filed 2025-03-26 | |
| 2022-09-30 | $399.26M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $421.04M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $228.71M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $250.97M 10-K · filed 2024-03-21 | |
| 2021-09-30 | $270.01M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $288.38M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $305.99M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $321.22M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $334.98M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$83.89M 10-Q · filed 2021-11-10 | -$83.89M 10-Q · filed 2020-08-20 |
| 2020-03-31 | -$33.69M 10-Q · filed 2021-11-10 | -$33.69M 10-Q · filed 2020-08-20 |
| 2019-12-31 | -$25.48M 10-K · filed 2022-03-17 | -$25.48M 10-Q · filed 2020-08-20 |
| 2019-09-30 | -$15.57M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$13.14M 10-Q · filed 2020-11-12 | -$13.14M 10-Q · filed 2020-08-20 |
| 2019-03-31 | -$8.39M 10-Q · filed 2020-11-12 | -$8.39M 10-Q · filed 2020-08-20 |
| 2018-12-31 | -$5.40M 10-K · filed 2021-03-25 | -$5.40M 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |